Does the administration of meloxicam before head and neck radiotherapy reduce the risk of mandibular osteoradionecrosis? An animal model study

Does the administration of meloxicam before head and neck radiotherapy reduce the risk of mandibular osteoradionecrosis? An animal model study

Mayra Cristina Yamasaki, Gina Delia Roque-Torres, Leonardo Vieira Peroni, Eduarda Helena Leandro Nascimento, Benjamin Salmon, Matheus Lima Oliveira, Deborah Queiroz Freitas, Lourenço Correr-Sobrinho

ARTIGO

Inglês

Agradecimentos: The authors would like to thank the Oncology Center of the Hospital Fornecedores de Cana for the assistance during the experimental phase of the study. This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil (CAPES)-Finance Code 001

To assess whether the administration of meloxicam before head and neck radiotherapy reduces the risk of mandibular osteoradionecrosis in rats. Sixty male Wistar rats were randomly divided into 6 groups (n = 10) according to the meloxicam administration and radiation therapy: control (C), irradiated...

COORDENAÇÃO DE APERFEIÇOAMENTO DE PESSOAL DE NÍVEL SUPERIOR - CAPES

Fechado

Does the administration of meloxicam before head and neck radiotherapy reduce the risk of mandibular osteoradionecrosis? An animal model study

Mayra Cristina Yamasaki, Gina Delia Roque-Torres, Leonardo Vieira Peroni, Eduarda Helena Leandro Nascimento, Benjamin Salmon, Matheus Lima Oliveira, Deborah Queiroz Freitas, Lourenço Correr-Sobrinho


										

Does the administration of meloxicam before head and neck radiotherapy reduce the risk of mandibular osteoradionecrosis? An animal model study

Mayra Cristina Yamasaki, Gina Delia Roque-Torres, Leonardo Vieira Peroni, Eduarda Helena Leandro Nascimento, Benjamin Salmon, Matheus Lima Oliveira, Deborah Queiroz Freitas, Lourenço Correr-Sobrinho

    Fontes

    Clinical oral investigations

    Vol. 25 (June, 2021), p. 3739-3745